Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2017; 49(06): 1319-1326
DOI: 10.1055/s-0036-1588102
DOI: 10.1055/s-0036-1588102
paper
Catalytic Alkylation of 2-Aryl-2-oxazoline-4-carboxylic Acid Esters Using Cyclopeptoids; Newly Designed Phase-Transfer Catalysts
Further Information
Publication History
Received: 13 September 2016
Accepted after revision: 27 October 2016
Publication Date:
24 November 2016 (online)
![](https://www.thieme-connect.de/media/synthesis/201706/lookinside/thumbnails/ss-2016-t0632-op_10-1055_s-0036-1588102-1.jpg)
Abstract
Nonionic, chiral macrocyclic peptoids are efficient phase-transfer catalysts in the C-4 enantioselective alkylation of 2-[4-(trifluoromethyl)phenyl]-2-oxazoline-4-carboxylic acid esters. Screening of the structural features of cyclic peptoids, namely the ring size, symmetry elements, number of proline residues, and substituents on the side chains, showed that the alternated N-(4-methoxybenzyl)glycine/l-proline cyclohexapeptoid is the optimal catalyst (good yields and up to 75% ee) for the stereocontrolled construction of α-alkylated serine tert-butyl esters.
Key words
organocatalysis - asymmetric catalysis - phase-transfer catalysis - peptidomimetics - cyclopeptoids - α,α-dialkyl-α-amino acidSupporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0036-1588102.
- Supporting Information
-
References
- 1a Bella M, Gasperi T. Synthesis 2009; 1583
- 1b Liu Y, Han S.-J, Liu W.-B, Stoltz BM. Acc. Chem. Res. 2015; 48: 740
- 1c Vetica F, de Figueiredo RM, Orsini M, Tofani D, Gasperi T. Synthesis 2015; 44: 2139
- 2a Vogt H, Bräse S. Org. Biomol. Chem. 2007; 5: 406
- 2b Cabrera S, Reyes E, Alemán J, Milelli A, Kobbelgaard S, Jørgensen KA. J. Am. Chem. Soc. 2008; 130: 12031
- 2c Zhou J. Org. Chem.: Curr. Res. 2014; 3: e136 ; http://www.omicsonline.org/organic-chemistry-current-research.php
- 3 O’Donnell MJ, Wu S. Tetrahedron: Asymmetry 1992; 3: 591
- 4a Jew Ss, Park H.-g. Chem. Commun. 2009; 7090
- 4b Hashimoto T, Maruoka K. Chem. Rev. 2007; 107: 5656
- 4c Shirakawa S, Maruoka K. Angew. Chem. Int. Ed. 2013; 52: 4312
- 4d Tan J, Yasuda N. Org. Process Res. Dev. 2015; 19: 1731
- 4e Kaneko S, Kumatabara Y, Shirakawa S. Org. Biomol. Chem. 2016; 14: 5367
- 5a Corey EJ, Xu F, Noe MC. J. Am. Chem. Soc. 1997; 119: 1414
- 5b Lygo B, Crosby J, Peterson JA. Tetrahedron Lett. 1999; 40: 8671
- 5c Lygo B, Crosby J, Peterson JA, Wainwright PG. Tetrahedron 2001; 57: 2403
- 5d Jew Ss, Jeong BS, Yoo M.-S, Huh H, Park H.-g. Chem. Commun. 2001; 1244
- 5e Jew Ss, Jeong BS, Lee J.-H, Yoo M.-S, Lee Y.-J, Park B.-s, Kim MG, Park H.-g. J. Org. Chem. 2003; 68: 4514
- 6a Ooi T, Takeuchi M, Kameda M, Maruoka K. J. Am. Chem. Soc. 2000; 122: 5228
- 6b Ooi T, Uematsu Y, Kameda M, Maruoka K. Angew. Chem. Int. Ed. 2002; 41: 1551
- 6c Kano T, Lan Q, Wang X, Maruoka K. Adv. Synth. Catal. 2007; 349: 556
- 6d Shirakawa S, Ueda M, Tanaka Y, Hashimoto T, Maruoka K. Chem. Asian J. 2007; 2: 1276
- 7a Belokon YN, Kochetkov KA, Churkina TD, Ikonnikov NS, Chesnokov AA, Larionov OV, Singh I, Parmar VS, Vyskocil S, Kagan HB. J. Org. Chem. 2000; 65: 7041
- 7b Belokon YN, North TD, Churkina TD, Ikonnikov NS, Maleev VI. Tetrahedron 2001; 57: 2491
- 7c Ohshima T, Shibuguchi T, Fukuta Y, Shibasaki M. Tetrahedron 2004; 60: 7743
- 7d Waser M, Gratzer K, Herchi R, Muller N. Org. Biomol. Chem. 2012; 10: 251
- 7e Lygo B, Butt U, Cormack M. Org. Biomol. Chem. 2012; 10: 4968
- 8 Halpern M. Phase Transfer Catalysis. In Ullman’s Encyclopedia of Industrial Chemistry. Vol. 26. Wiley-VCH; Weinheim: 2012: 495
- 9a Itoh T, Shirakami S. Heterocycles 2001; 55: 37
- 9b Yonezawa K, Patil ML, Sasai H, Takizawa S. Heterocycles 2005; 66: 639
- 10 Rapi Z, Grün A, Keglevich G, Stirling A, Bakó P. New J. Chem. 2016; 40: 7856
- 11a Schettini R, Nardone B, De Riccardis F, Della Sala G, Izzo I. Eur. J. Org. Chem. 2014; 7793
- 11b Schettini R, De Riccardis F, Della Sala G, Izzo I. J. Org. Chem. 2016; 81: 2494
- 12a Culf AS, Ouellette R. Molecules 2010; 15: 5282; http://www.mdpi.com/journal/molecules
- 12b Yoo B, Shin SB. Y, Huang ML, Kirshenbaum K. Chem. Eur. J. 2010; 16: 5528
- 12c Tedesco C, Erra L, Izzo I, De Riccardis F. CrystEngComm 2014; 16: 3667
- 13a Maulucci N, Izzo I, Bifulco G, Aliberti A, Comegna D, Gaeta C, Napolitano A, Pizza C, Tedesco C, Flot D, De Riccardis F. Chem. Commun. 2008; 3927
- 13b Izzo I, Ianniello G, De Cola C, Nardone B, Erra L, Vaughan G, Tedesco C, De Riccardis F. Org. Lett. 2013; 15: 598
- 13c De Cola C, Fiorillo G, Meli A, Aime S, Gianolio E, Izzo I, De Riccardis F. Org. Biomol. Chem. 2014; 12: 424
- 14a De Cola C, Licen S, Comegna D, Cafaro E, Bifulco G, Izzo I, Tecilla P, De Riccardis F. Org. Biomol. Chem. 2009; 7: 2851
- 14b Comegna D, Benincasa M, Gennaro R, Izzo I, De Riccardis F. Bioorg. Med. Chem. 2010; 18: 2010
- 15 Yamashita T, Iijima M, Nakamura H, Issiki K, Naganawa H, Hattori S, Hamada M, Ishizuka M, Takeuchi T, Iitaka Y. J. Antibiot. 1991; 44: 557
- 16a Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Chiba K, Hoshino Y, Okumoto T. J. Antibiot. 1994; 47: 216
- 16b Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Chiba K, Hoshino Y, Okumoto T. J. Antibiot. 1994; 47: 208
- 16c Strader CR, Pearce CJ, Oberlies NH. J. Nat. Prod. 2011; 74: 900
- 17a Sasaki S, Hashimoto R, Kiuchi M, Inoue K, Ikumoto T, Hirose R, Chiba K, Hoshino Y, Okumoto T, Fujita T. J. Antibiot. 1994; 47: 420
- 17b Fujita T, Hamamichi N, Kiuchi M, Matsuzaki T, Kitao Y, Inoue K, Hirose R, Yoneta M, Sasaki S, Chiba K. J. Antibiot. 1996; 49: 846
- 18 Frązczak O, Lasota A, Leśniak A, Lipkowski AW, Olma A. Chem. Biol. Drug Des. 2014; 84: 199
- 19 Jew S.-s, Lee Y.-J, Lee J, Kang MJ, Jeong B.-S, Lee J.-H, Yoo M.-S, Kim M.-J, Choi S.-h, Ku J.-M, Park H.-g. Angew. Chem. Int. Ed. 2004; 43: 2382
- 20 Nakayama K, Maruoka K. Tetrahedron Lett. 2008; 49: 5461
- 21a Denoël T, Zervosen A, Lemaire C, Joris B, Hervé M, Blanot D, Zaragoza G, Luxena A. Org. Biomol. Chem. 2014; 12: 9853
- 21b Denoël T, Zervosen A, Lemaire C, Plenevaux A, Luxena A. Tetrahedron 2014; 70: 4526
- 22 Lee Y.-J, Lee J, Kim M.-J, Kim T.-S, Park H.-g, Jew S.-s. Org. Lett. 2005; 7: 1557
- 23a Uraguchi D, Asai Y, Seto Y, Ooi T. Synlett 2009; 658
- 23b Tarí S, Avila A, Chinchilla R, Nájera C. Tetrahedron: Asymmetry 2012; 23: 176
- 23c Duan S, Li S, Ye X, Du N.-N, Tan C.-H, Jiang Z. J. Org. Chem. 2015; 80: 7770
- 24 Lee Y.-J, Lee J, Kim M.-J, Jeong B.-S, Lee J.-H, Kim T.-S, Lee J, Ku S.-s, Jew S.-s, Park H.-g. Org. Lett. 2005; 7: 3207
- 25 Le Corre L, Gravier-Pelletier C, Le Merrer Y. Eur. J. Org. Chem. 2007; 5386
For recent reviews on asymmetric phase-transfer catalysis see:
For selected examples, see:
For selected examples, see:
For recent reviews on cyclopeptoids:
For examples of PTC alkylation of related substrates, such as azlactones and oxazol-4(5H)-ones, see: